SCHEMBL6096484

SCHEMBL6096484

O=C1C=C(O)C(=O)C(c2c[nH]c3cc(Cl)ccc23)=C1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDH1 O75874 1/20 0.41
ALDH1A1 P00352 2/20 0.41
DYRK1A Q13627 2/20 0.40
NR4A2 P43354 1/20 0.40
GPR84 Q9NQS5 1/20 0.40
GSK3B P49841 1/20 0.40
MDM2 Q00987 2/20 0.39
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
KMT2A Q03164 1/20 0.37
IDO1 P14902 1/20 0.37
PTPN1 P18031 1/20 0.37
CDK4 P11802 1/20 0.36
CCND1 P24385 1/20 0.36
PRKCB P05771 1/20 0.36
PRKCA P17252 1/20 0.36
PRKCH P24723 1/20 0.36
PRKCE Q02156 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6096745 0.90 F7 (0.44) NR4A2GPR84IDO1PTPN1SLC6A4
SCHEMBL6094665 0.84 NR4A2 (0.41) ALDH1A1NR4A2MEN1KMT2AIDO1
SCHEMBL6094700 0.84 IMPDH2 (0.45) GSK3BIDO1PTPN1CDK4CCND1
SCHEMBL6095097 0.84 TDO2 (0.46) IDO1CDK4CCND1
SCHEMBL6097125 0.81 PRKCB (0.54) GSK3BPTPN1CDK4CCND1PRKCB
SCHEMBL6095741 0.78 TSHR (0.40) ALDH1A1MEN1CYP1A2CYP3A4CYP2D6
SCHEMBL6099085 0.76 KDM4E (0.44) ALDH1A1NR4A2MEN1KMT2AIDO1
SCHEMBL6096702 0.76 IGF1R (0.44) ALDH1A1GPR84IDO1SLC6A4
SCHEMBL6096806 0.76 EGFR (0.44) NR4A2GPR84GSK3BCYP1A2IDO1
SCHEMBL6094956 0.76 ALDH1A1 (0.43) IDH1ALDH1A1DYRK1ANR4A2GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7057052-B2 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY (US) 2006-06-06 US disclosed
WO-2004050014-A2 SETEROCYCLIC QUINONES AS PHARMACEUTICAL AGENTS DUKE UNIVERSITY (US) 2004-06-17 WO disclosed
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents DUKE UNIVERSITY 2004-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063774-A1 Heterocyclic quinones as pharmaceutical agents NQO1, RECQL, SDHA IDH1 46/4885ALDH1A1 609/4885DYRK1A 2359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.